Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB.
Saif MW, et al. Among authors: russo s.
Cancer J. 2007 Jul-Aug;13(4):247-56. doi: 10.1097/PPO.0b013e31813c12b8.
Cancer J. 2007.
PMID: 17762760
Clinical Trial.
PATIENTS AND METHODS: Twenty patients received 50.4 Gy XRT with capecitabine 1,600 mg/m(2) on Monday through Friday for 6 weeks determined from our phase I study (Saif MW, Eloubeidi MA, Russo S, et al. J Clin Oncol. 2005;23:8679-8687). After capecitabine-XRT, stable …
PATIENTS AND METHODS: Twenty patients received 50.4 Gy XRT with capecitabine 1,600 mg/m(2) on Monday through Friday for 6 weeks determined f …